tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gregory Renza, 207 are a BUY (81.18%), 48 are a HOLD (18.82%).
Analyst Gregory Renza, currently employed at RBC, carries an average stock price target met ratio of 43.45% that have a potential upside of 37.52% achieved within 106 days.
Gregory Renza’s has documented 498 price targets and ratings displayed on 39 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EXEL, Exelixis at 08-Jul-2025.
Analyst best performing recommendations are on SPRB (SPRUCE BIOSCIENCES ).
The best stock recommendation documented was for SPRB (SPRUCE BIOSCIENCES ) at 3/13/2024. The price target of $2 was fulfilled within 1 day with a profit of $3.19 (61.46%) receiving and performance score of 614.64.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$33
$11.2 (51.38%)
$34
11 days ago
(28-Sep-2025)
8/13 (61.54%)
$11.68 (54.78%)
113
Buy
$28
$6.2 (28.44%)
$30
16 days ago
(23-Sep-2025)
0/10 (0%)
$6.74 (31.70%)
Buy
$39
$17.2 (78.90%)
$35
29 days ago
(10-Sep-2025)
7/12 (58.33%)
$14.8 (61.16%)
671
Buy
$39
$17.2 (78.90%)
$32
1 months 1 days ago
(08-Sep-2025)
1/5 (20%)
$14.16 (57.00%)
349
Hold
$24
$2.2 (10.09%)
$23
2 months 3 days ago
(06-Aug-2025)
10/13 (76.92%)
$-0.4 (-1.64%)
157
Which stock is Gregory Renza is most bullish on?
Which stock is Gregory Renza is most reserved on?
What Year was the first public recommendation made by Gregory Renza?
